Razi Imam is an accomplished award winning CEO of 113 Industries. He has experience in launching products in highly competitive and regulated markets. He has founded 113 Industries that focuses on using AI and Machine Learning to develop Patient Behavior Models that provide clear understanding on Patient Journey, their emotional commitment toward a treatment and successful adoption of therapy. 113’s Patient Behavior Models have been applied in launching drugs and therapies related to Bone Metastasis, Duchene Muscular Dystrophy, Head and Neck Cancer, Early Stage Lung Cancer, Small Cell Lung Cancer and Personalized Healthcare. He was also a former adjunct professor at Carnegie Mellon university focusing on innovation and commercialization.